Schisandrin B Ameliorates Myocardial Ischemia/Reperfusion Injury Through Attenuation of Endoplasmic Reticulum Stress-Induced Apoptosis

Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases

(2016) Mei-qing Liu et al.   ACTA PHARMACOLOGICA SINICA

Chemical Chaperone 4-Phenylbutyric Acid Reduces Cardiac Ischemia/Reperfusion Injury by Alleviating Endoplasmic Reticulum Stress and Oxidative Stress

(2016) Lian Jian et al.   MEDICAL SCIENCE MONITOR

Evolving Therapies for Myocardial Ischemia/Reperfusion Injury

(2015) Borja Ibáñez et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury

(2015) Dongsheng Yu et al.   LIFE SCIENCES

Ischemia/reperfusion injury: Effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition

(2014) Claudia Duehrkop et al.   BIOCHEMICAL PHARMACOLOGY

Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-κB

(2012) Rahul Checker et al.   FREE RADICAL BIOLOGY AND MEDICINE

C/EBP Homologous Protein (CHOP) Deficiency Aggravates Hippocampal Cell Apoptosis and Impairs Memory Performance

(2012) Chang-Mu Chen et al.   PLoS One

Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress

(2011) Ira Tabas et al.   NATURE CELL BIOLOGY

Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo

(2011) Yang Xu et al.   PLoS One

The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

(2011) P. Walter et al.   SCIENCE

Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine

(2008) Alexander Panossian et al.   JOURNAL OF ETHNOPHARMACOLOGY